Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05UDU
|
||||
| Former ID |
DIB005870
|
||||
| Drug Name |
YK-3237
|
||||
| Synonyms |
Angiogenesis inhibitors (cancer); YK-3237; Angiogenesis inhibitors (cancer), Georgetown University
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543687] | ||
| Company |
Georgetown University
|
||||
| Canonical SMILES |
c1(c(c(cc(c1)C(=O)/C=C/c1ccc(c(c1)B(O)O)OC)OC)OC)OC
|
||||
| Target and Pathway | |||||
| Target(s) | NAD-dependent deacetylase sirtuin-1 | Target Info | Inhibitor | [543687] | |
| PANTHER Pathway | p53 pathway | ||||
| Pathway Interaction Database | p73 transcription factor network | ||||
| Signaling events mediated by HDAC Class III | |||||
| E2F transcription factor network | |||||
| HIF-2-alpha transcription factor network | |||||
| Signaling events mediated by HDAC Class I | |||||
| FoxO family signaling | |||||
| Regulation of Androgen receptor activity | |||||
| Regulation of retinoblastoma protein | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.